Michelle A Albert, MD, MPH
Dr. Michelle A. Albert is a Professor in Medicine and Cardiologist at the University of California at San Francisco (UCSF) and founding director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center). The UCSF NURTURE Center is an interdisciplinary translational research center seeks to perform exploratory and interventional scientific research to understand the "biology of adversity" and its impact on health, particularly cardiovascular health. Research in the NURTURE Center seeks to decipher and develop novel initiatives aimed at improving patient behavior and adherence taking into account the interplay between social determinants of health and biological processes to attain advantaged health and well-being of persons at risk across the life-course.
Dr. Albert is a graduate of Haverford College (Chemistry), University of Rochester School of Medicine, Harvard School of Public Health (Epidemiology/Clinical Effectiveness), completed Internal Medicine Residency and served as Chief Medical Resident at Columbia University, New York. She trained in Cardiovascular Medicine and did a research fellowship at Brigham and Women's Hospital and Harvard Medical School in Boston MA where she was an Associate Professor in Medicine. She completed a one year Brigham Executive Leadership Program at Harvard Business School. Dr. Albert was previously the Vivian Beaumont Allen Endowed Professor and Chief of Cardiology at Howard University. She is a general cardiologist with clinical expertise involving taking care of the most critically ill advanced heart disease patients, as well as preventive cardiology with a focus on vulnerable populations.
Dr. Albert is a current Board Member and President-Elect of the American Heart Association San Francisco/Bay Area Board. She was Vice-President and Board Member of the Association of Black Cardiologists, a member of the National Academy of Sciences Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease and serves as a reviewer for multiple journals including currently serving on the Editorial Board of Circulation and as Section Editor for Current Cardiovascular Risk Reports (Disparities). Dr Albert is an elected member of the Association of University Cardiologists. She served/s on several national committees of the American College of Cardiology and American Heart Association (AHA) including as a member of the Epidemiology Council, the AHA National Research Committee, the AHA Executive Steering Committee of the 2012 Women's Triennial Health Tracking Study in Heart Disease and Stroke Executive, Committee-Clinical Cardiology Council, Science Advisory and Coordinating Committee, and as Chair of the AHA Executive Database Steering Committee.
Dr. Albert is a recipient of several research awards, including R01 funding from the National Institutes of Health/Aging, the Doris Duke Foundation, Robert Wood Johnson Foundation (Harold Amos Faculty Development Award), Brigham and Women's Hospital (Minority Faculty Development Award, the Learner Cardiovascular Young Investigator Award, the Nikki Harris Family Cardiovascular Research Award and the Herbert Nickens Epidemiology Award from the Association of Black Cardiologists. She is also recipient of the American College of Cardiology's (ACC) 2012 Heart of Women's Health Credo Award, Woman's Day Magazine's Red Dress Award (2014), the Haverford College Alumni Award (2015) that recognizes an alumnus who reflects Haverford's concern with the uses to which they put their knowledge, humanity, initiative and individuality. Dr. Albert enjoys mentoring trainees at all levels across the United States and was nominated for the competitive 2011-2012 Excellence in Mentoring Award at Harvard Medical School. Dr. Albert is the recipient of the 2016 American Heart Association Women in Cardiology Mentoring Award.
Awards and Honors
Elected Member, Association of University Cardiologists, 2016
Women in Cardiology Mentoring Award, American Heart Association, 2016
The Haverford Award, recognizing an alumnus who uses their knowledge to the benefit of society, Haverford College, 2015
Red Dress Award Honoree, Women's Day Magazine, 2014
Featured "Editor's Choice & Scientist": MA Health Care Reform, Race/Ethnicity and CVD, Circulation Journal (June 17, 2014), 2014
Second Annual Heart of Women's Health CREDO Award, American College of Cardiology, 2012
Nesson Fellowship Award, Brigham and Women’s Hospital, Boston MA, 2010
J Ira and Nikki Harris Family Research Award, Brigham and Women's Hospital, Boston MA, 2006
Herbert W. Nickens Epidemiology Award, Association of Black Cardiologists, Inc, 2004
Learner Young Investigator Award,, Brigham and Women’s Hospital, Boston MA, 2003
Brigham and Women's Hospital/Kraft Minority Faculty Development Award, Brigham and Women’s Hospital, Boston MA, 2001
Related Web Sites
In the News
- AHA/ACC Fellows on the Go (FIT blog) (Nov 16, 2016)
- AHA/ACC Fellows on the Go (FIT blog) (Nov 16, 2016)
- AHA 2020 Goals: Cardiovascular Health for All Americans ... Health (Mar 20, 2014)
- Higher job strain associated with increased cardiovascular risk for women (Dec 07, 2012)
- Putting the stress on stress (Dec 27, 2010)
- The Hidden Epidemic: Heart Disease in America . PBS
- Traumatic Life Events May Threaten Women's Heart Health
- Traumatic life events may threaten women's heart health
Recent Articles (53)
- Albert MA, Durazo EM, Slopen N, Zaslavsky AM, Buring JE, Silva T, Chasman D, Williams DR. Cumulative psychological stress and cardiovascular disease risk in middle aged and older women: Rationale, design, and baseline characteristics. Am Heart J. 2017 Oct; 192:1-12.
- Cuevas AG, Williams DR, Albert MA. Psychosocial Factors and Hypertension: A Review of the Literature. Cardiol Clin. 2017 May; 35(2):223-230.
- Slopen N, Chen Y, Guida JL, Albert MA, Williams DR. Positive childhood experiences and ideal cardiovascular health in midlife: Associations and mediators. Prev Med. 2017 Apr; 97:72-79.
- Hira RS, Bhatt DL, Fonarow GC, Heidenreich PA, Ju C, Virani SS, Bozkurt B, Petersen LA, Hernandez AF, Schwamm LH, Eapen ZJ, Albert MA, Liang L, Matsouaka RA, Peterson ED, Jneid H. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. J Am Heart Assoc. 2016 Oct 06; 5(10).
- Cozier YC, Albert MA, Castro-Webb N, Coogan PF, Ridker P, Kaufman HW, Palmer JR, Rosenberg L. Neighborhood Socioeconomic Status in Relation to Serum Biomarkers in the Black Women's Health Study. J Urban Health. 2016 Apr; 93(2):279-91.
- Slopen N, Chen Y, Priest N, Albert MA, Williams DR. Emotional and instrumental support during childhood and biological dysregulation in midlife. Prev Med. 2016 Mar; 84:90-6.
- Slopen N, Non A, Williams DR, Roberts AL, Albert MA. Childhood adversity, adult neighborhood context, and cumulative biological risk for chronic diseases in adulthood. Psychosom Med. 2014 Sep; 76(7):481-9.
- Albert MA, Ayanian JZ, Silbaugh TS, Lovett A, Resnic F, Jacobs A, Normand SL. Early results of Massachusetts healthcare reform on racial, ethnic, and socioeconomic disparities in cardiovascular care. Circulation. 2014 Jun 17; 129(24):2528-38.
- Redmond N, Richman J, Gamboa CM, Albert MA, Sims M, Durant RW, Glasser SP, Safford MM. Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke study. J Am Heart Assoc. 2013 Dec 19; 2(6):e000447.
- Albert MA. Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction. Circulation. 2014 Feb 18; 129(7):723-4.
- Slopen N, Kontos EZ, Ryff CD, Ayanian JZ, Albert MA, Williams DR. Psychosocial stress and cigarette smoking persistence, cessation, and relapse over 9-10 years: a prospective study of middle-aged adults in the United States. Cancer Causes Control. 2013 Oct; 24(10):1849-63.
- Plitt A, Dorbala S, Albert MA, Giugliano RP. Cardiac sarcoidosis: case report, workup, and review of the literature. Cardiol Ther. 2013 Dec; 2(2):181-97.
- Clark CR, Ommerborn MJ, Hickson DA, Grooms KN, Sims M, Taylor HA, Albert MA. Neighborhood disadvantage, neighborhood safety and cardiometabolic risk factors in African Americans: biosocial associations in the Jackson Heart study. PLoS One. 2013; 8(5):e63254.
- Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation. 2013 Mar 19; 127(11):1254-63, e1-29.
- Powell-Wiley TM, Ayers CR, de Lemos JA, Lakoski SG, Vega GL, Grundy S, Das SR, Banks-Richard K, Albert MA. Relationship between perceptions about neighborhood environment and prevalent obesity: data from the Dallas Heart Study. Obesity (Silver Spring). 2013 Jan; 21(1):E14-21.
- Slopen N, Glynn RJ, Buring JE, Lewis TT, Williams DR, Albert MA. Job strain, job insecurity, and incident cardiovascular disease in the Women's Health Study: results from a 10-year prospective study. PLoS One. 2012; 7(7):e40512.
- Tsenkova VK, Albert MA, Georgiades A, Ryff CD. Trait anxiety and glucose metabolism in people without diabetes: vulnerabilities among black women. Diabet Med. 2012 Jun; 29(6):803-6.
- Slopen N, Dutra LM, Williams DR, Mujahid MS, Lewis TT, Bennett GG, Ryff CD, Albert MA. Psychosocial stressors and cigarette smoking among African American adults in midlife. Nicotine Tob Res. 2012 Oct; 14(10):1161-9.
- Lee TC, Glynn RJ, Peña JM, Paynter NP, Conen D, Ridker PM, Pradhan AD, Buring JE, Albert MA. Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. PLoS One. 2011; 6(12):e27670.
- Albert MA. Biomarkers and heart disease. J Clin Sleep Med. 2011 Oct 15; 7(5 Suppl):S9-11.
- Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, Zhang SM, Buring JE. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012 Jan; 33(1):159-71.
- Albert MA, Glynn RJ, Fonseca FA, Lorenzatti AJ, Ferdinand KC, MacFadyen JG, Ridker PM. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Am Heart J. 2011 Jul; 162(1):106-14.e2.
- Albert MA, Williams DR. Invited commentary: Discrimination--an emerging target for reducing risk of cardiovascular disease? Am J Epidemiol. 2011 Jun 01; 173(11):1240-3.
- Powell TM, de Lemos JA, Banks K, Ayers CR, Rohatgi A, Khera A, McGuire DK, Berry JD, Albert MA, Vega GL, Grundy SM, Das SR. Body size misperception: a novel determinant in the obesity epidemic. Arch Intern Med. 2010 Oct 11; 170(18):1695-7.
- Moukarbel GV, Albert MA. The ecology of stent thrombosis: a view from a sociobiological perspective. Circulation. 2010 Sep 14; 122(11):1053-5.
- Albert MA. Receipt of high-quality coronary heart disease care in the United States: all about being black or white: comment on "Racial differences in admissions to high-quality hospitals for coronary heart disease". Arch Intern Med. 2010 Jul 26; 170(14):1216-7.
- Slopen N, Lewis TT, Gruenewald TL, Mujahid MS, Ryff CD, Albert MA, Williams DR. Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med. 2010 Sep; 72(7):694-701.
- Albert MA, Cozier Y, Ridker PM, Palmer JR, Glynn RJ, Rose L, Halevy N, Rosenberg L. Perceptions of race/ethnic discrimination in relation to mortality among Black women: results from the Black Women's Health Study. Arch Intern Med. 2010 May 24; 170(10):896-904.
- Cook NR, Albert MA. Regarding REGARDS: Does inflammation explain racial and regional differences in cardiovascular disease risk? Clin Chem. 2009 Sep; 55(9):1603-5.
- Albert MA, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee RY. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women's Genome Health Study. Am Heart J. 2009 Apr; 157(4):777-83.e1.
- Conen D, Glynn RJ, Ridker PM, Buring JE, Albert MA. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J. 2009 Jun; 30(11):1378-84.
- Albert MA. Heart failure in the urban African enclave of Soweto: a case study of contemporary epidemiological transition in the developing world. Circulation. 2008 Dec 02; 118(23):2323-5.
- Albert MA, Ravenell J, Glynn RJ, Khera A, Halevy N, de Lemos JA. Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. Am Heart J. 2008 Dec; 156(6):1103-9.
- Albert MA. Race/ethnicity and inflammation: is there a link to periodontal disease? J Periodontol. 2008 Jul; 79(7):1121-3.
- Albert MA. Inflammatory biomarkers, race/ethnicity and cardiovascular disease. Nutr Rev. 2007 Dec; 65(12 Pt 2):S234-8.
- Albert MA, Glynn RJ, Buring JE, Ridker PM. Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis. 2008 Mar; 197(1):297-302.
- Albert MA, Glynn RJ, Buring JE, Ridker PM. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. Am J Cardiol. 2007 May 01; 99(9):1246-51.
- Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation. 2006 Dec 12; 114(24):2619-26.
- Albert MA, Ridker PM. C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation. 2006 Aug 01; 114(5):e67-74.
- Albert MA, Glynn RJ, Wolfert RL, Ridker PM. The effect of statin therapy on lipoprotein associated phospholipase A2 levels. Atherosclerosis. 2005 Sep; 182(1):193-8.
- Unic D, Mihaljevic T, Leacche M, Gasparovic H, Albert MA, Byrne JG. Surgical treatment of a large left-main coronary artery aneurysm. Thorac Cardiovasc Surg. 2004 Aug; 52(4):230-1.
- Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 2004 Jul 13; 110(2):e7-12.
- Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004 May 15; 93(10):1238-42.
- Albert MA, Glynn RJ, Ridker PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004 Jan 15; 93(2):221-5.
- Albert MA, Ridker PM. Inflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis. Rev Cardiovasc Med. 2004; 5 Suppl 3:S22-7.
- Blake GJ, Albert MA, Rifai N, Ridker PM. Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial. Eur Heart J. 2003 Oct; 24(20):1843-7.
- Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003 Jul 15; 108(2):161-5.
- Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003 Jan 28; 107(3):443-7.
- Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001 Jul 04; 286(1):64-70.
- Albert MA, Staggers J, Chew P, Ridker PM. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design. Am Heart J. 2001 Jun; 141(6):893-8.
- Albert MA, Rifai N, Ridker PM. Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis. Vasc Med. 2001; 6(3):145-9.
- Albert MA. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep. 2000 Jul; 2(4):274-9.
- Albert MA, Ridker PM. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep. 1999 Jul; 1(2):99-104.